References
- Murphy JW. Protective cell-mediated immunity against Crypto-coccus neoformans. Res Immunol 1998; 149:373–386.
- Powderly, WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis Supp11992; 1: S54–S59.
- Huffnagle GB, Lipscomb MF. Pulmonary cryptococcosis. Am J Pathol 1992; 141: 1517–1520.
- Huffnagle GB, Lipscomb MF. Cells and cytokines in pulmonary cryptococcosis. Res Immunol 1998; 149:387–396.
- Lipscomb MF, Izzo A, Wilder JA, et aL Factors regulating effective T-cell immunity in the lung. Eur Respir Rev 2000; 10: 103–107.
- Huffnagle GB, Yates JL, Lipscomb MF. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 1991; 59: 1423–1433.
- Hoag KA, Street NE, Huffnagle GB, et al. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995; 13: 487–495.
- Hoag KA, Lipscomb MF, Izzo AA, et al. IL-12 and IFN-gamma are required for initiating the protective Thl response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997; 17: 733–739.
- Birkedal-Hansen, B. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995; 7: 728–735.
- Goetzl El, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996; 156: 1–4.
- Preece G, Murphy G, Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem 1996; 271: 11634–11640.
- Ohnishi K, Takagi M, Kurokawa Y, et aL Matrix metallopro-teinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78: 1077–1087.
- Nagase H, Woessner, JF. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491–21494.
- Stetler-Stevenson, WG. Matrix metalloproteinases in angiogen-esis: a moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237–1241.
- Chang JC, Wysocki A, Tchou-Wong KM, et al. Effect of Mycobacterium tuberculosis and its components on macro-phages and the release of matrix metalloproteinases. Thorax 1996; 51: 306–311.
- Firth JD, Putnins EE, Larjava H, et aL Bacterial phospholipase C upregulates matrix metalloproteinase expression by cultured epithelial cells. Infect Immun 1997; 65: 4931–4936.
- Busiek DF, Ross FP, McDonnell S, et al. The matrix metallo-protease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem 1992; 267: 9087–9092.
- Pierce RA, Sandefur G, Doyle GAR, et aL Monocytic cell type-specific transcriptional induction of collagenase. J Clin Invest 1996; 97: 1890–1899.
- Gibbs DF, Warner RL, Weiss SJ, et aL Characterization of matrix metalloproteinases produced by rat alveolar macro-phages. J Am J Respir Cell Mol Biol 1999; 20: 1136–1144.
- Gibbs DF, Shanley TS, Warner RL, et al. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Am J Respir Cell Mol Biol 1999; 20: 1145–1154.
- Ibrahim-Granet O, Hernandez FH, Chevrier G, et al. Expres-sion of PZ-peptidases by cultures of several pathogenic fungi. Purification and characterization of a ollagenase from Tricho-phyton schoenleinii. J Med Vet Mycol 1996; 34: 83–90.
- Kaushal GP, Sudhir VS. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. J Clin Invest 2000; 105: 1335–1337.
- Zhang Y, McCluskey K, Fujii K, et aL Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-a, granulocyte-macrophage CSF, and IL-1I3 through prostaglandin-dependent and -independent mechanisms. J Im-munol 1998; 161: 3071–3076.
- Kindler V, Sappino AP, Grau GE, et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 7317–7340.
- Huffnagle GB, Toews GB, Burdick MD, et aL Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996; 157: 4529–4536.